RxNorm 117055
alemtuzumab
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 117055 unique identifier include: alemtuzumab (833578), Alemtuzumab (833584), Alemtuzumab (substance) (833592), Product containing alemtuzumab (medicinal product) (9723274) and Alemtuzumab-containing product (10795871).
RxNorm Atom ID: 833578 - Ingredient
alemtuzumab
- RXCUI:
- 117055 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 833578 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- alemtuzumab - Description of concept identifier
- Term Type (TTY):
- IN - Term type in source with name and description
- Term Type Name:
- Ingredient - Name of term type in source
- Term Type Description:
- A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). - Description of term type in source
- Code:
- 117055 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- RxNorm to UNII Crosswalk:
- 3A189DH42V - ALEMTUZUMAB () - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- April 01, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 833584 - Designated preferred name
Alemtuzumab
- RXCUI:
- 117055 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 833584 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Alemtuzumab - Description of concept identifier
- Term Type (TTY):
- PT - Term type in source with name and description
- Term Type Name:
- Designated preferred name - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 129472003 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- RxNorm to UNII Crosswalk:
- 3A189DH42V - ALEMTUZUMAB () - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- April 01, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 833592 - Full form of descriptor
Alemtuzumab (substance)
- RXCUI:
- 117055 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 833592 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Alemtuzumab (substance) - Description of concept identifier
- Term Type (TTY):
- FN - Term type in source with name and description
- Term Type Name:
- Full form of descriptor - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 129472003 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- RxNorm to UNII Crosswalk:
- 3A189DH42V - ALEMTUZUMAB () - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- April 01, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 9723274 - Full form of descriptor
Product containing alemtuzumab (medicinal product)
- RXCUI:
- 117055 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 9723274 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Product containing alemtuzumab (medicinal product) - Description of concept identifier
- Term Type (TTY):
- FN - Term type in source with name and description
- Term Type Name:
- Full form of descriptor - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 391632007 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- RxNorm to UNII Crosswalk:
- 3A189DH42V - ALEMTUZUMAB () - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- April 01, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 10795871 - Designated preferred name
Alemtuzumab-containing product
- RXCUI:
- 117055 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10795871 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Alemtuzumab-containing product - Description of concept identifier
- Term Type (TTY):
- PT - Term type in source with name and description
- Term Type Name:
- Designated preferred name - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 391632007 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- RxNorm to UNII Crosswalk:
- 3A189DH42V - ALEMTUZUMAB () - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- April 01, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Alemtuzumab Injection (Chronic Lymphocytic Leukemia)
Alemtuzumab injection is used to treat B-cell chronic lymphocytic leukemia (B-CLL; a slowly developing cancer in which too many of a certain type of white blood cell accumulate in the body). Alemtuzumab is in a class of medications called monoclonal antibodies. It works by activating the immune system to destroy cancer cells. Alemtuzumab is also available as an injection (Lemtrada) that is used to treat multiple sclerosis (a disease in which the nerves do not function properly; you may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control). This monograph only gives information about alemtuzumab injection (Campath) for B-CLL. If you are receiving alemtuzumab for multiple sclerosis, read the monograph entitled Alemtuzumab Injection (Multiple Sclerosis).
[Learn More]
Alemtuzumab Injection (Multiple Sclerosis)
Alemtuzumab injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) who have not improved with at least two or more MS medications including: relapsing-remitting forms (course of disease where symptoms flare up from time to time) or secondary progressive forms (course of disease where relapses occur more often). Alemtuzumab is in a class of medications called monoclonal antibodies. It works by decreasing the action of immune cells that may cause nerve damage. Alemtuzumab is also available as an injection (Campath) that is used to treat chronic lymphocytic leukemia (a slowly developing cancer in which too many of a certain type of white blood cell accumulates in the body). This monograph only gives information about alemtuzumab injection (Lemtrada) for multiple sclerosis. If you are receiving alemtuzumab for chronic lymphocytic leukemia, read the monograph entitled Alemtuzumab Injection (Chronic Lymphocytic Leukemia).
[Learn More]
* Please review the disclaimer below.